KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vertex Pharmaceuticals (VRTX) Current Assets (2016 - 2025)

Historic Current Assets for Vertex Pharmaceuticals (VRTX) over the last 17 years, with Q4 2025 value amounting to $11.2 billion.

  • Vertex Pharmaceuticals' Current Assets rose 1672.09% to $11.2 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $11.2 billion, marking a year-over-year increase of 1672.09%. This contributed to the annual value of $11.2 billion for FY2025, which is 1672.09% up from last year.
  • Per Vertex Pharmaceuticals' latest filing, its Current Assets stood at $11.2 billion for Q4 2025, which was up 1672.09% from $10.6 billion recorded in Q3 2025.
  • In the past 5 years, Vertex Pharmaceuticals' Current Assets ranged from a high of $14.7 billion in Q3 2023 and a low of $8.5 billion during Q2 2021
  • Its 5-year average for Current Assets is $11.1 billion, with a median of $10.5 billion in 2025.
  • In the last 5 years, Vertex Pharmaceuticals' Current Assets skyrocketed by 5678.81% in 2021 and then crashed by 3554.63% in 2024.
  • Quarter analysis of 5 years shows Vertex Pharmaceuticals' Current Assets stood at $9.6 billion in 2021, then skyrocketed by 38.43% to $13.2 billion in 2022, then grew by 6.87% to $14.1 billion in 2023, then plummeted by 32.15% to $9.6 billion in 2024, then grew by 16.72% to $11.2 billion in 2025.
  • Its Current Assets was $11.2 billion in Q4 2025, compared to $10.6 billion in Q3 2025 and $10.4 billion in Q2 2025.